Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-011519

Chief Medical Officer gave up 2,183 shares (to pay taxes)

  • Chief Medical Officer acquired 1,800 shares (grant or award)
  • Chief Medical Officer acquired 6,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Harris Matthew Scott · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-31 Grant or award : show line 1 in the form +1,800 $6.86 $12,348 7,562 D
2022-02-01 Exercise or conversion : show line 2 in the form +6,166 13,728 D
2022-02-01 Shares withheld for taxes : show line 3 in the form −2,183 $7.98 $17,420 11,545 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-02-01 Exercise or conversion : show line 4 in the form Restricted Stock Units −6,166 18,498 D
2022-02-02 Grant or award : show line 5 in the form Stock Options (option to buy) +91,600 91,600 D
2022-02-02 Grant or award : show line 6 in the form Restricted Stock Units +31,100 31,100 D
Loading xslF345X03/tm225504-3_4seq1.xml…